全文获取类型
收费全文 | 583290篇 |
免费 | 50653篇 |
国内免费 | 18283篇 |
专业分类
耳鼻咽喉 | 7807篇 |
儿科学 | 10269篇 |
妇产科学 | 9384篇 |
基础医学 | 72527篇 |
口腔科学 | 16197篇 |
临床医学 | 47581篇 |
内科学 | 69207篇 |
皮肤病学 | 8943篇 |
神经病学 | 30336篇 |
特种医学 | 18683篇 |
外国民族医学 | 222篇 |
外科学 | 55860篇 |
综合类 | 92219篇 |
现状与发展 | 87篇 |
一般理论 | 29篇 |
预防医学 | 45688篇 |
眼科学 | 7596篇 |
药学 | 57863篇 |
414篇 | |
中国医学 | 41863篇 |
肿瘤学 | 59451篇 |
出版年
2024年 | 594篇 |
2023年 | 8637篇 |
2022年 | 12657篇 |
2021年 | 22568篇 |
2020年 | 21829篇 |
2019年 | 22549篇 |
2018年 | 21719篇 |
2017年 | 21559篇 |
2016年 | 21337篇 |
2015年 | 21691篇 |
2014年 | 33832篇 |
2013年 | 38385篇 |
2012年 | 33475篇 |
2011年 | 37475篇 |
2010年 | 28889篇 |
2009年 | 27130篇 |
2008年 | 28402篇 |
2007年 | 29897篇 |
2006年 | 27224篇 |
2005年 | 24381篇 |
2004年 | 20693篇 |
2003年 | 18229篇 |
2002年 | 14570篇 |
2001年 | 12982篇 |
2000年 | 10914篇 |
1999年 | 9108篇 |
1998年 | 7174篇 |
1997年 | 6875篇 |
1996年 | 6058篇 |
1995年 | 6000篇 |
1994年 | 5482篇 |
1993年 | 4505篇 |
1992年 | 4017篇 |
1991年 | 3718篇 |
1990年 | 3078篇 |
1989年 | 2747篇 |
1988年 | 2606篇 |
1987年 | 2258篇 |
1986年 | 2076篇 |
1985年 | 3824篇 |
1984年 | 3744篇 |
1983年 | 2530篇 |
1982年 | 2974篇 |
1981年 | 2248篇 |
1980年 | 1989篇 |
1979年 | 1672篇 |
1978年 | 1251篇 |
1977年 | 958篇 |
1976年 | 1059篇 |
1975年 | 701篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
《Saudi Pharmaceutical Journal》2022,30(7):954-963
BackgroundThe continuing expansion of the pharmacist’s role necessitates continuous evaluation of current practice to identify strategies for improvements. The International Pharmaceutical Federation (FIP) has developed tools to support stakeholders in identifying development needs and planning advancement strategies. The aim of this research was to utilise the FIP Global Competency Framework, version 2 (GbCF v2), and FIP Development Goals (DGs) to evaluate competencies related to pharmacy practice in Saudi Arabia, and to understand the strategies needed to develop and improve the current practice.MethodsThe study involved four phases. Phase 1 involved translation of the FIP GbCF v2 into the Arabic language. Phase 2 was a consensus panel validation to establish the initial relevance of the competencies to current practice. Phase 3 included a national survey distributed to all registered pharmacists in Saudi Arabia. The final phase was conducted through mapping ‘not relevant’ competencies to FIP DGs to identify priorities.ResultsThe translation phase yielded a bilingual framework that could be utilized by pharmacists in Saudi Arabia. The initial validation phase identified 61 behavioral statements (from 124 in the GbCF v2) as ‘highly relevant’ or ‘relevant’ to pharmacy practice. Findings from the national survey identified a list of ‘not relevant’ competencies that could highlight gaps in current practice. The final mapping phase generated a list of three FIP DG priorities: DG5 (competency development), DG8 (working with others) and DG11 (impact and outcomes).ConclusionThe study indicated that competencies in the GbCF v2 were relevant to pharmacists practicing in the country. However, some competencies were perceived as ‘not relevant’ to current practice and these highlighted gaps in the current practice that need attention. Mapping ‘not relevant’ competencies to FIP DGs should be used as a starting point towards developing strategies, systems, and protocols to advance pharmacy practice in Saudi Arabia. 相似文献
72.
Pharmaceutical compounds (PCs) have globally emerged as a significant group of environmental contaminants due to the constant detection of their residues in the environment. The main scope of this review is to fill the void of information on the knowledge on the African occurrence of selected PCs in environmental matrices in comparison with those outside Africa and their respective toxic actions on both aquatic and non-aquatic biota through ecotoxicity bioassays. To achieve this objective, the study focused on commonly used and detected pharmaceutical drugs (residues). Based on the conducted literature survey, Africa has the highest levels of ciprofloxacin, sulfamethoxazole, lamivudine, acetaminophen, and diclofenac while Europe has the lowest of all these PC residues in her physical environments. For ecotoxicity bioassays, the few data available are mostly on individual groups of pharmaceuticals whereas there is sparsely available data on their combined forms. 相似文献
73.
《Drug discovery today》2022,27(4):1108-1114
This project demonstrates the use of the IEEE 2791–2020 Standard (BioCompute Objects [BCO]) to enable the complete and concise communication of results from next generation sequencing (NGS) analysis. One arm of a clinical trial was replicated using synthetically generated data made to resemble real biological data and then two independent analyses were performed. The first simulated a pharmaceutical regulatory submission to the US Food and Drug Administration (FDA) including analysis of results and a BCO. The second simulated an FDA review that included an independent analysis of the submitted data. Of the 118 simulated patient samples generated, 117 (99.15%) were in agreement in the two analyses. This process exemplifies how a template BCO (tBCO), including a verification kit, facilitates transparency and reproducibility, thereby reinforcing confidence in the regulatory submission process. 相似文献
74.
High Order Finite Difference Hermite WENO Fixed-Point Fast Sweeping Method for Static Hamilton-Jacobi Equations 下载免费PDF全文
In this paper, we combine the nonlinear HWENO reconstruction in [43] and
the fixed-point iteration with Gauss-Seidel fast sweeping strategy, to solve the static
Hamilton-Jacobi equations in a novel HWENO framework recently developed in [22].
The proposed HWENO frameworks enjoys several advantages. First, compared with
the traditional HWENO framework, the proposed methods do not need to introduce
additional auxiliary equations to update the derivatives of the unknown function $\phi$.
They are now computed from the current value of $\phi$ and the previous spatial derivatives of $\phi$. This approach saves the computational storage and CPU time, which greatly
improves the computational efficiency of the traditional HWENO scheme. In addition,
compared with the traditional WENO method, reconstruction stencil of the HWENO
methods becomes more compact, their boundary treatment is simpler, and the numerical errors are smaller on the same mesh. Second, the fixed-point fast sweeping method
is used to update the numerical approximation. It is an explicit method and does
not involve the inverse operation of nonlinear Hamiltonian, therefore any Hamilton-Jacobi equations with complex Hamiltonian can be solved easily. It also resolves some
known issues, including that the iterative number is very sensitive to the parameter $ε$ used in the nonlinear weights, as observed in previous studies. Finally, to further
reduce the computational cost, a hybrid strategy is also presented. Extensive numerical experiments are performed on two-dimensional problems, which demonstrate the
good performance of the proposed fixed-point fast sweeping HWENO methods. 相似文献
75.
《Value in health》2022,25(12):1958-1966
ObjectivesNational health technology assessments (HTAs) across Europe show differences in evidentiary requirements from assessments by the European Medicines Agency (EMA), affecting time to patient access for drugs after marketing authorization. This article analyzes the differences between EMA and HTA bodies’ evidentiary requirements for oncology drugs and provides recommendations on potential further alignment to minimize and optimally manage the remaining differences.MethodsInterviews were performed with representatives and drug assessment experts from EMA and HTA bodies to identify evidentiary requirements for several subdomains and collect recommendations for potentially more efficiently addressing differences. A comparative analysis of acceptability of the evidence by EMA and the HTA bodies and for potential further alignment between both authorities was conducted.ResultsAcceptability of available evidence was higher for EMA than HTA bodies. HTA bodies and EMA were aligned on evidentiary requirements in most cases. The subdomains showing notable differences concerned the acceptance of limitation of the target population and extrapolation of target populations, progression-free survival and (other) surrogate endpoints as outcomes, cross-over designs, short trial duration, and clinical relevance of the effect size. Recommendations for reducing or optimally managing differences included joint early dialogues, joint relative effectiveness assessments, and the use of managed entry agreements.ConclusionsDifferences between assessments of EMA and HTA bodies were identified in important areas of evidentiary requirements. Increased alignment between EMA and HTA bodies is suggested and recommendations for realization are discussed. 相似文献
76.
目的:分析比较"F"形空心钉与传统倒三角3枚平行螺钉内固定治疗青壮年Pauwels Ⅲ型股骨颈骨折的临床疗效。方法:2017年1月至2020年1月收治Pauwels Ⅲ型股骨颈骨折患者38例,根据置入钉方式的不同将其分为两组,其中A组18例,采用"F"形空心钉固定,男12例,女6例,年龄37~55岁,受伤至手术时间1~3 d。B组20例,采用传统倒三角3枚平行拉力螺钉固定,男12例,女8例,年龄35~55岁,受伤至手术时间为1~3 d。比较两组患者骨折不愈合,股骨头坏死,股骨颈短缩,空心螺钉退出情况,髋关节功能Harris评分,疼痛视觉模拟评分(visual analogue scale,VAS)。结果:所有患者获得随访,时间为15~31个月。两组患者在骨折不愈合,股骨颈短缩,股骨头坏死方面差异无统计学意义(P>0.05);两组患者在螺钉退出方面差异有统计学意义(P<0.05)。两组患者术后12个月时髋关节Harris评分及VAS评分差异均无统计学差异(P>0.05)。结论:"F"形与传统倒三角3枚平行空心钉内固定治疗青壮年Pauwels Ⅲ型股骨颈骨折中短期疗效相似,但"F"形空心钉退钉率较低。 相似文献
77.
78.
79.
80.
PurposeOptical coherence tomography angiography (OCTA) was utilized to examine changes in ocular surface squamous neoplasia (OSSN) vascular patterns over time in individuals treated with topical medical therapy.MethodsTen individuals with OSSN diagnosed by clinical examination and high resolution (HR)-optical coherence tomography (OCT) were recruited. All individuals received topical immuno- or chemotherapy. OCTA images were obtained and analyzed at three points: presentation, mid-treatment and tumor resolution. Tumor metrics including tumor area (TA), tumor volume (TV), tumor depth (TD), and total tumor density (TTD) were calculated. Vessel area density (VAD) was also quantified within the OSSN, the subepithelium under and adjacent to the OSSN and the subepithelium of the uninvolved, contralateral eye. Vascular network changes were also subjectively evaluated.ResultsTA, TV, TD and TTD all significantly decreased with time (p < 0.001). The mean VAD within the OSSN significantly decreased (p < 0.001) between visits (presentation: 26.52 ± 6.8%, mid-treatment: 7.19 ± 5.88%, tumor resolution: 0.11 ± 0.34%). The mean subepithelial VAD under the OSSN also decreased with time (23.22 ± 11.03%, 20.99 ± 5.99% and 19.58 ± 7.08%), and after resolution the sub-tumor VAD (19.58 ± 7.08%) was comparable to the subepithelial VAD in the contralateral eye (15.47 ± 4.37%, p > 0.05). The mean VAD in the subepithelium adjacent to the OSSN increased with treatment, then decreased significantly between mid-treatment and resolution (23.26 ± 4.54, 28.30 ± 7.43% and 21.68 ± 6.10%, p = 0.009). Qualitatively, the tumor subepithelial vascular network was complex and dense but with tumor resolution appeared less tortuous and similar to the uninvolved eye.ConclusionOCTA provided insight into the pathophysiology of tumor angiogenesis, showing decreased vascular density and normalization of vascular networks associated with tumor resolution. 相似文献